Following two quarters of growth, venture capital funding in the life science sector fell 18 percent during the third quarter of 2011, according to PricewaterhouseCoopers report. According to the report, venture capitalists invested $1.8 billion in 170 life sciences deal – which includes biotechnology and medical device industries. It’s the lowest number of deals since […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly If you're already a member, sign in here.